A lawsuit has gone to jury trial in Los Angeles, alleging that the manufacturer of the diabetes drug Actos concealed its cancer risks, Bloomberg reports.
The plaintiff’s lawyer claims that internal studies by Takeda, Asia’s biggest drug manufacturer, uncovered Actos’s links to bladder cancer as early as 2004. But the company didn’t alert U.S. regulators until seven years later, in order to protect more than $1.6 billion in annual sales.
Other diabetes ...
continue reading...